Renaissance Capital logo

COMPASS Pathways Priced, Nasdaq: CMPS

British Phase 2 biotech developing a psilocybin-based therapy for depression.

Industry: Health Care

Latest Trade: $43.17 0.00 (0.0%)

First Day Return: +70.6%

Return from IPO: +153.9%

Industry: Health Care

We are a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies, and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Our initial focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the current treatment paradigm. We have developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. In 2019, we completed a Phase I clinical trial administering COMP360, along with psychological support, to 89 healthy volunteers, the largest randomized controlled clinical trial with psilocybin therapy to date. In this trial we observed that COMP360 was generally well-tolerated. We are currently evaluating COMP360 in conjunction with psychological support in a Phase IIb trial and we plan to report data from this trial in late 2021. We believe that a single dose of our COMP360 monotherapy with psychological support from specially trained therapists could offer a new approach to depression care.
more less
IPO News for COMPASS Pathways
more
IPO Data
IPO File Date 08/28/2020
Offer Price $17.00
Price Range $14.00 - $16.00
Offer Shares (mm) 7.5
Deal Size ($mm) $128
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/17/2020
Offer Price $17.00
Price Range $14.00 - $16.00
Offer Shares (mm) 7.5
Deal Size ($mm) $128
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Cheshire, United Kingdom
Founded 2015
Employees 48
Website www.compasspathways.com